Features

Medical Marijuana Advocacy

State of the state regulations regarding medicinal cannabis

Editor's note: This is the fourth article in a four-part series that will introduce you to the world of medical cannabis. In the series, we'll cover: the endogenous cannabinoid system; the science behind medical cannabis; the plant's chemical composition, including main components THC and CBD; the different varieties of cannabis and what they're used for; delivery methods, dosing, interactions; and finally, cannabis advocacy and where we are in the fight to legalize medical cannabis in the United States.

"There was a time in the United States when extracts of cannabis were almost as commonly used for medicinal purposes as is aspirin today," wrote Solomon Snyder in a 1971 book entitled Uses of Marijuana. In fact, the history of marijuana medical use predates the written word. Every civilization since the dawn of man has employed the unique therapeutic properties of this plant. The Chinese were medically using cannabis twenty-eight centuries before the birth of Christ, recommending it for a variety of disorders including rheumatic pain and constipation. In cultures widely separated by geography and time there are consistent reports of marijuana's medical benefits easing digestive upsets, enhancing appetites, relieving muscle spasms and reducing melancholia.1 

Today, the United States boasts a patchwork of medical cannabis laws. States that have legalized the plant for medicinal purposes have unique rules and regulations, qualifying conditions and allowable medicines. Where a patient lives in the country impacts his or her ability to legally access cannabinoid therapies: If a patient experiencing debilitating chronic pain lives in Connecticut, Georgia, Maine, New Jersey, or New York, he or she cannot legally access medicinal cannabis. If that same patient lived in one of the other 20 states that legalized medical cannabis, he or she would be able to do so.  

1996-2016: Twenty Years of Medical Cannabis in the U.S.
Since 1996, twenty-five states and the District of Columbia have adopted laws that permit the cultivation, processing, distribution and possession of cannabis for medicinal purposes.  Another seventeen states have adopted laws that permit the possession of cannabis extracts high in cannabidiol (CBD) and low in THC.  Additionally, four states-Colorado, Washington, Oregon, Alaska-and the District of Columbia currently allow adults to consume cannabis for recreational purposes.

In the beginning, California, Oregon, and Washington passed laws to protect qualified patients from arrest and prosecution and allowed them to cultivate limited amounts of cannabis. Distribution models were non-profit, member-based collectives with members providing their excess cannabis to those in need. In 2010, Colorado was the first state to classify medical cannabis distribution as a "business" regulat­ed under the state's Department of Revenue, formally creating the medical cannabis industry.2

SEE ALSO: Poll: Medical Marijuana in the Workplace

In the current medical cannabis industry, most state-sanctioned programs regulate production and distribution processes in order to protect patients. West Coast states give patients a broad array of medicines and delivery methods to choose from, from raw flower for vaporization to potent extracted oils. Depending on the nature of the political landscape, some state programs are barely functional. Too few dispensaries, limited qualifying conditions, restricted THC, capital requirements, and aggressive timelines harm patients who could greatly benefit from this medicine.

Patients in Minnesota, New York, and Pennsylvania only have access to processed cannabis extracts in the form of tinctures, extracts for inhalation, oral mucosal sprays and capsules with limited ratios of cannabinoids. The prohibition of qualified patients from using the actual plant unnecessarily eliminates the safest and most affordable route of administration and has had the unintended consequence of empowering a robust black market of unregulated cannabis with no quality control or quality assurance measures. 

DEA and Drug Scheduling
Despite the fact that half of the states allow cannabis to be used for medical purposes and people across all 50 states are advocating for the federal government to legalize the plant, on Thursday August 11, 2016, the U.S. Drug Enforcement Agency (DEA) announced that it would uphold its current position that cannabis has no currently accepted medical use and a high potential for abuse. This decision leaves cannabis on Schedule 1 which is the same classification as heroin, lysergic acid diethylaminde (LSD), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.3 The DEA's decision was a big blow to advocates across the country who would like to see the federal government once again recognize the medicinal value of cannabis. This announcement did reveal, however, that the DEA would expand the number of sites that can cultivate cannabis for research so there is reason to believe the federal government may revisit this decision in the future.

Medical Cannabis and the November 2016 Election
pill boxOn November 8, 2016, voters nationwide will cast their ballots. In four states-Arkansas, Florida, Missouri and Montana-voters will decide if medical marijuana should be legal. In five states-Arizona, California, Maine, Massachusetts and Nevada-voters will decide whether or not marijuana should be legal for recreational use.4

Despite the recent DEA decision and no matter the outcome of the November election, medical cannabis in the United States is here to stay. Regardless of where you live, cannabis is going to become part of the arsenal you will carry in order to provide patients with the best possible quality of life. Educate yourself about the laws in your states. Advocate on behalf of your patients, they deserve it!

References

1. Marijuana in America: Memoir of a Pioneer. Middletown: n.p., 2016. N. pag. Print.

2. ASA. "Medical Marijuana Access in the US." Medical Marijuana Access in the US. Americans for Safe Access, Jan. 2016. Web. 21 Aug. 2016.

3. "DEA / Drug Scheduling." DEA / Drug Scheduling. United States Department of Justice, n.d. Web. 22 Aug. 2016.

4. Wallace, Alicia. "Definitive Guide to Marijuana on the 2016 Ballot: Recreational & Medical Initiatives." The Cannabist. The Denver Post, 14 July 2016. Web. 22 Aug. 2016.

Eileen Konieczny is president of the American Cannabis Nurses Association.


You Might Also Like...

Part 1: What Nurses Need to Know About Cannabis

Understanding the science behind the endogenous cannabinoid system.

Part 2: Differences Between Natural and Synthetic Cannabinoid Medicines

Change the variety or chemical "recipe" and you change the therapeutic effect.

Part 3: Cannabis Dosing and Administration

Patients have different delivery methods for medicinal cannabis.

Title

Blurb


Articles Archives
 

Margaret Brady. You have been mislead thinking that there is "non-medical" cannabis. All cannabis is medical, even the recreational kind. Cannabis plant in nature is not dangerous. Actually it can be healthier. The dangers come when you need to buy cannabis from criminals, who deal all kinds of drugs. Also driving a car with a relaxed and focused mind via cannabis can be good for many people. Many people drive their car with enormous amounts of stress and that can lead to accidents. And God is not there to help you at all.
As to these 4 great articles, which I've translated in Finnish and published, I must say they are great!

Artur PonomarevNovember 21, 2016



I cannot believe medical cannabis is not available to all who need it for debilitating side effects of chemo, etc. As with most things, we do not control that which we should control (illegal drugs),but work very hard to place control on that which could help so many. Some people are very backward in their thinking. BTW I do not approve of non medical cannabis:it can be very dangerous, esp when drivers use it and YES, people do drive and use: (God help us all).
MBrady

Margaret Brady,  Nurse PractitionerOctober 06, 2016
Boston, MA




     

Email: *

Email, first name, comment and security code are required fields; all other fields are optional. With the exception of email, any information you provide will be displayed with your comment.

First * Last
Name:
Title Field Facility
Work:
City State
Location:

Comments: *
To prevent comment spam, please type the code you see below into the code field before submitting your comment. If you cannot read the numbers in the below image, reload the page to generate a new one.

Captcha
Enter the security code below: *

Fields marked with an * are required.

View the Latest from ADVANCE

 

Search Jobs

Go
 
 
 

Back to Top

© 2017 Merion Matters

660 American Avenue Suite 300, King of Prussia PA 19406

1-484-804-4888